[1]梅冬环.参麦注射液治疗急性心肌梗死的疗效及对患者心肌损伤的影响[J].医学信息,2019,32(23):156-158.[doi:10.3969/j.issn.1006-1959.2019.23.049]
　MEI Dong-huan.Effect of Shenmai Injection on Acute Myocardial Infarction and its Effect on Myocardial Injury[J].Medical Information,2019,32(23):156-158.[doi:10.3969/j.issn.1006-1959.2019.23.049]
点击复制

参麦注射液治疗急性心肌梗死的疗效及对患者心肌损伤的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年23期
页码:
156-158
栏目:
中医中药
出版日期:
2019-12-01

文章信息/Info

Title:
Effect of Shenmai Injection on Acute Myocardial Infarction and its Effect on Myocardial Injury
文章编号:
1006-1959（2019）23-0156-03
作者:
梅冬环
（寻乌县人民医院急诊科，江西 寻乌 342200）
Author(s):
MEI Dong-huan
(Department of Emergency,Xunwu County People’s Hospital,Xunwu 342200,Jiangxi,China)
关键词:
参麦注射液; 急性心肌梗死; hs-CRP; NT-proBNP; 心肌损伤
Keywords:
Shenmai injection; Acute myocardial infarction; hs-CRP; NT-proBNP; Myocardial injury
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2019.23.049
文献标志码:
A
摘要:
目的 探究参麦注射液治疗急性心肌梗死患者的临床疗效以及对血清超敏C反应蛋白（hs-CRP）、N端B型利钠肽前体（NT-proBNP）、心肌损伤标志物的影响。方法 选取2017年6月~2018年12月我院治疗的急性心肌梗死患者86例作为研究对象，按照随机数字表法分为观察组和对照组，每组43例。对照组给予常规西药治疗，观察组在对照组基础上加用参麦注射液治疗，比较两组治疗前后血清hs-CRP、NT-proBNP、心肌损伤标志物水平、临床疗效、心血管不良事件（MACE）发生情况。结果 治疗后，观察组hs-CRP、NT-proBNP水平低于对照组[（10.92±1.65）mg/L vs（18.39±3.03）mg/L]、[（234.41±28.34）ng/L vs（314.65±36.14）ng/L]，差异有统计学意义（P＜0.05）。观察组AST、CK-MB及MYO水平低于对照组[（31.17±3.96）U/L vs（43.86±7.52）U/L]、[（6.18±1.02）ng/ml vs（10.34±1.66）ng/ml]、[（38.42±7.61）ng/ml vs（56.19±10.12）ng/ml]，差异有统计学意义（P＜0.05）。观察组总有效率为90.70%，高于对照组的72.09%，差异有统计学意义（P＜0.05）。两组MACE发生率比较，差异无统计学意义（P＞0.05）。结论 参麦注射液有助于降低心肌梗死患者hs-CRP和NT-proBNP水平，改善患者心肌受损情况，提高临床疗效，安全可靠。
Abstract:
Objective To explore the clinical efficacy of Shenmai injection in the treatment of patients with acute myocardial infarction and the effects of serum high-sensitivity C-reactive protein (hs-CRP), N-terminal B-type natriuretic peptide precursor (NT-proBNP), and myocardial injury markers.Methods 86 patients with acute myocardial infarction treated in our hospital from June 2017 to December 2018 were selected as the study subjects. According to the random number table method, they were divided into observation group and control group, with 43 cases in each group. The control group was treated with conventional western medicine. The observation group was treated with Shenmai injection on the basis of the control group.Serum hs-CRP, NT-proBNP, myocardial injury marker levels, clinical efficacy, and cardiovascular adverse events (MACE) were compared before and after treatment.Results After treatment, the levels of hs-CRP and NT-proBNP in the observation group were lower than those in the control group [(10.92±1.65) mg/L vs (18.39±3.03) mg/L], [(234.41±28.34) ng/L vs (314.65±36.14) ng / L], the difference was statistically significant (P<0.05). The AST, CK-MB and MYO levels in the observation group were lower than those in the control group [(31.17±3.96) U/L vs (43.86±7.52) U/L], [(6.18±1.02) ng/ml vs (10.34±1.66) ng /ml], [(38.42±7.61) ng/ml vs (56.19±10.12) ng/ml], the difference was statistically significant (P<0.05). The total effective rate of the observation group was 90.70%, which was higher than that of the control group 72.09%,the difference was statistically significant (P<0.05). There was no significant difference in the incidence of MACE between the two groups (P>0.05). Conclusion Shenmai injection can help to reduce the levels of hs-CRP and NT-proBNP in patients with myocardial infarction, improve myocardial damage, improve clinical efficacy, and be safe and reliable.

参考文献/References:

[1]汪占祥,冯建飞,陈聪玲,等.参麦注射液辅助治疗急性心肌梗死的临床疗效及对血清超敏C反应蛋白、降钙素原水平的影响研究[J].实用心脑肺血管病杂志,2016,24(3):125-126.[2]杜亚康.参麦注射液配合瑞通立溶栓治疗前壁急性心肌梗死再灌注损伤的临床研究[J].陕西中医,2017,38(2):171-173.[3]谭璐,汪曲,杨峰,等.阿魏酸钠+参麦注射液方案用于急性心肌梗死辅助治疗的临床价值研究[J].海南医学院学报,2018,24(17):1547-1550,1554.[4]王华,刘劲松,许绍信.参麦注射液对急性心肌梗死患者经皮冠脉介入治疗术后心肌和微血管的保护作用[J].现代中西医结合杂志,2017,26(11):1201-1203.[5]沈卫峰,张奇,张瑞岩.2015年急性ST段抬高型心肌梗死诊断和治疗指南解析[J].国际心血管病杂志,2015,42(4):217-219.[6]燕军,程明月,段洋,等.参麦注射液联合阿替普酶治疗急性心肌梗死的临床效果研究[J].现代生物医学进展,2018,18(22):4294-4297.[7]施保柱,杨明华,董妍,等.参麦注射液治疗急性ST段抬高型心肌梗死合并心源性休克的疗效及机制研究[J].中国医院药学杂志,2018,38(23):2459-2463,2488.[8]顾永林,郭俊林,蒋灵霓,等.急性ST段抬高性心肌梗死患者再灌注治疗后心肌损伤指标动态变化的价值[J].中国循证心血管医学杂志,2016,8(9):1119-1121.[9]张德龙,殷莉,姜芳,等.参麦注射液联合左西孟旦治疗老年急性心肌梗死合并心源性休克的临床研究[J].现代中西医结合杂志,2018,27(13):1453-1457.[10]陈丽俐,喻伟成.参麦注射液治疗急性心肌梗死并发心力衰竭的疗效观察[J].江西医药,2016,51(7):656-657.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Medical Information,2018,31(23):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Medical Information,2018,31(23):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
　HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Medical Information,2022,35(23):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[4]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Medical Information,2018,31(23):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[5]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Medical Information,2018,31(23):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[6]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,32(23):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[7]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(23):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[8]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(23):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[9]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[10]马洪俊,王玉平,刘 毅.主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果[J].医学信息,2022,35(13):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]
　MA Hong-jun,WANG Yu-ping,LIU Yi.Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure[J].Medical Information,2022,35(23):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]

更新日期/Last Update: 2019-12-01